Sign in
Taking people in NetherlandsPhase 1

PET tracer study in leg artery disease and healthy volunteers

Tests a PET tracer in leg artery disease and healthy people.

Key facts

Who runs it
Aplagon Oy
Where
Groningen, NetherlandsSee the site
Registry title
Safety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical limb ischemia (PAOD/CLI) and healthy volunteers – an open label PET study (CHASE-study)
Status
Recruiting
Phase
Phase 1
People taking part
10 people, planned
Started
1 Feb 2024
Planned end
31 Aug 2024
Type of study
Interventional
Record updated
27 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with peripheral arterial occlusive disease or critical limb ischemia, and also healthy volunteers. It tests the safety and spread in the body of a PET scan tracer called [89Zr]Zr-DFO-APAC.

Age
18 years and older
Sex
All sexes
Disease stage
Peripheral arterial occlusive disease (blocked leg arteries) or critical limb ischemia (severe lack of blood flow to a limb). Healthy volunteers can also join.

Where in Netherlands

  • University Medical Center GroningenGroningen, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
PET tracer study in leg artery disease and healthy volunteersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
27 February 2026